Have a personal or library account? Click to login

Application of Novel Methods for Non-Small Cell Lung Cancer (Nsclc) Biomarker Discovery

Acta Chirurgica Latviensis
Volume 13 (2013): Issue 1 (December 2013)
By:
Open Access
|Sep 2013

References

  1. 1. Aoki T, Tsuchida M, Watanabe T, Hashimoto T, Koike T, Hirono T, Hayashi J. Surgical strategy for clinical stage I non-small cell lung cancer in octogenarians. // Eur J Cardiothorac Surg, 2003; 23(4):446-450.10.1016/S1010-7940(03)00014-9
    Search in Google Scholar
  2. 2. Balgkouranidou I, Liloglou T, Lianidou ES. Lung cancer epigenetics: emerging biomarkers. // Biomark Med, 2013; 7(1):49-58.10.2217/bmm.12.111
    Search in Google Scholar
  3. 3. Chida M, Minowa M, Karube Y, Eba S, Okada Y, Miyoshi S, Kondo T. Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymphnode dissection. // Interact CardioVasc Thorac Surg, 2009; 8(1):89-92.10.1510/icvts.2008.193383
    Search in Google Scholar
  4. 4. Das-Neves-Pereira JC, Bagan P, Coimbra-Israel AP, Grimaillof-Junior A, Cesar-Lopez G, Milanez-de- Campos JR, Riquet MR, Biscegli-Jatene F. Fasttrack rehabilitation for lung cancer lobectomy: a five-year experience. // Eur J Cardiothorac Surg, 2009; 36(2):383-392.10.1016/j.ejcts.2009.02.020
    Search in Google Scholar
  5. 5. Gao WM, Kuick R, Orchekowski RP, et al. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. // BMC Cancer, 2005; 5:110.10.1186/1471-2407-5-110
    Search in Google Scholar
  6. 6. Giovannetti R, Alifano M, Stefani A, Legras A, Grigoroiu M, Collet JY, Magdelenat P, Regnard JF. Surgical treatment of bronchiectasis: early and long-term results. // Interact CardioVasc Thorac Surg, 2008; 7(4):609-612.10.1510/icvts.2007.163972
    Search in Google Scholar
  7. 7. Ferguson MK, Celauro AD, Vigneswaran WT. Validation of a modified scoring system for cardiovascular risk associated with major lung resection. // Eur J Cardiothorac Surg, 2012; 41(3):598-602.10.1093/ejcts/ezr081
    Search in Google Scholar
  8. 8. Ferguson MK and Durkin AE. A comparison of three scoring systems for predicting complications after major lung resection. // Eur J Cardiothorac Surg, 2003; 23(1):35-42.10.1016/S1010-7940(02)00675-9
    Search in Google Scholar
  9. 9. Khan N, Cromer CJ, Campa M, et al. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. // Cancer, 2004; 101:379-384.10.1002/cncr.2037715241837
    Search in Google Scholar
  10. 10. Kojima F, Yamamoto K, Matsuoka K, Ueda M, Hamada H, Imanishi N, Miyamoto Y. Factors affecting survival after lobectomy with pulmonary artery resection for primary lung cancer. // Eur J Cardiothorac Surg, 2011; 40(1):13-20.10.1016/j.ejcts.2011.02.02621435895
    Search in Google Scholar
  11. 11. Kouritas VK, Zissis C and Bellenis I. Variation of the postoperative fluid drainage according to the type of lobectomy. // Interact CardioVasc Thorac Surg, 2013; 16(4):437-440.10.1093/icvts/ivs529
    Search in Google Scholar
  12. 12. López E, Cho WC. Phosphoproteomics and lung cancer research. // Int J Mol Sci, 2012; 13(10):12287-314.10.3390/ijms131012287
    Search in Google Scholar
  13. 13. Matsuoka H, Okada M, Sakamoto T, Tsubota N. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age. // Eur J Cardiothorac Surg, 2005; 28(3):380-383.10.1016/j.ejcts.2005.06.010
    Search in Google Scholar
  14. 14. Paesmans M. Prognostic and predictive factors for lung cancer. Review. // Eur Respir J Breathe, 2012; 9:113 - 122.
    Search in Google Scholar
  15. 15. Pastor MD, Nogal A, Molina-Pinelo S, Meléndez R, Romero-Romero B, Mediano MD, López-Campos JL, García-Carbonero R, Sanchez-Gastaldo A, Carnero A, Paz-Ares L. Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage. // Int J Mol Sci, 2013; 14(2):3440-55.10.3390/ijms14023440
    Search in Google Scholar
  16. 16. Patz EF Jr, Campa MJ, Gottlin EB, et al. Panel of serum biomarkers for the diagnosis of lung cancer. // J Clin Oncol, 2007; 25:5578-5583.10.1200/JCO.2007.13.5392
    Search in Google Scholar
  17. 17. Sakuragi T, Sakao Y, Furukawa K, Rikitake K, Ohtsubo S, Okazaki Y, Natsuaki M, Itoh T. Successful management of acute pulmonary embolism after surgery for lung cancer. // Eur J Cardiothorac Surg, 2003; 24(4):580-587.10.1016/S1010-7940(03)00392-0
    Search in Google Scholar
  18. 18. Szczesny TJ, Slotwinski R, Stankiewicz A, Szczygiel B, Zaleska M, Kopacz M. Interleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgery. // Eur J Cardiothorac Surg, 2007; 31(4):719-724.10.1016/j.ejcts.2007.01.02717317198
    Search in Google Scholar
  19. 19. Taenzer A, Alix-Panabières C, Wikman H, Pantel K. Circulating tumor-d erived biomarkers in lung cancer. // J Thorac Dis, 2012; 4(5):448-9.
    Search in Google Scholar
  20. 20. Wang Y, Hu Y, Wang D, Yu K, Wang L, Zou Y, Zhao C, Zhang X, Wang P, Ying K. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. // Cancer Biomark, 2012; 11(4):129-37. 10.3233/CBM-2012-0027023144150
    Search in Google Scholar
DOI: https://doi.org/10.2478/chilat-2013-0003 | Journal eISSN: 2199-5737 | Journal ISSN: 1407-981X
Journal RSS Feed
Language: English
Page range: 13 - 16
Published on: Sep 5, 2013
Published by: Riga Stradins University
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
biomarkers,
lung cancer,
lung resection
Related subjects:
Medicine,
Clinical medicine,
Surgery,
Surgery, other

© 2013 Artjoms Spaks, Ainis Pirtnieks, Jelena Grusina-Ujumaza, Jazeps Basko, Dainis Krievins, published by Riga Stradins University
This work is licensed under the Creative Commons License.

Previous articleVolume 13 (2013): Issue 1 (December 2013)Next article